Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
The hallmarks of successful anticancer immunotherapy — Lorenzo Galluzzi (2018) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The hallmarks of successful anticancer immunotherapy
Shared by
Guido Guido Kroemer
The hallmarks of successful anticancer immunotherapy
Article
2018
en
Authors
+2 more
LG
Lorenzo Galluzzi
TC
Timothy A. Chan
Guido Guido Kroemer
Abstract
1 min read
Various features of the tumor and immune system influence the success of immunotherapy.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2018
Nanomaterials for modulating innate immune cells in cancer immunotherapy
Quoc‐Viet Le
,
Geon Yang
,
Yina Wu
,
Ho Won Jang
,
Mohammadreza Shokouhimehr
,
Yu‐Kyoung Oh
Article
2024
Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy
Nasim Ebrahimi
,
Al‐Hasnawi Rasool Riyadh Abdulwahid
,
Atena Mansouri
,
Nasrin Karimi
,
Rashid Jafardoust Bostani
,
Sheida Beiranvand
,
Samaneh Adelian
,
Roya Khorram
,
Reza Vafadar
,
Michael R Hamblin
,
Amir Reza Aref
Article
2017
Trial watch: Dendritic cell-based anticancer immunotherapy
Abhishek D. Garg
,
Mónica Vara‐Pérez
,
Marco B.E. Schaaf
,
Patrizia Agostinis
,
Laurence Zitvogel
,
Guido Guido Kroemer
,
Lorenzo Galluzzi
Article
2022
The effect of organ-specific tumor microenvironments on response patterns to immunotherapy
Jordan W. Conway
,
Jorja Braden
,
James S. Wilmott
,
Richard A Scolyer
,
Georgina V. Long
,
Inês Pires da Silva
Article
2025
The dual role of chaperone-mediated autophagy in the response and resistance to cancer immunotherapy
Mohammadreza Saberiyan
,
Sarah Gholami
,
Mahsa Ejlalidiz
,
Mohammadsadegh Rezaeian Manshadi
,
Parisa Noorabadi
,
Michael R Hamblin
Discussion(0)
No comments yet. Be the first to comment.